Products
3777 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
| Code | Description | Unit |
|---|---|---|
| 1699027 | Tropicamide Related Compound B (50 mg) (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide) | 50 mg |
| 1699038 | Tropicamide Related Compound C (25 mg) (3-hydroxy-2-phenylpropionic acid) | 25 mg |
| 1699049 | Tropicamide Related Compound D (15 mg) (List Chemical) (2-phenylacetic acid) | 15 mg |
| 1699300 | Trospium Chloride (100 mg) | 100 mg |
| 1699311 | Trospium Chloride Related Compound A (20 mg) (Benzilic Acid) (International Restricted Sales Item) | 20 mg |
| 1699322 | Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate) | 20 mg |
| 1699333 | Trospium Chloride Related Compound C (20 mg) ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1'-pyrrolidinium]chloride) | 20 mg |
| 1700002 | Trypsin Crystallized (300 mg) (COLD SHIPMENT REQUIRED) | 300 mg |
| 1700013 | Trypsin Recombinant Porcine (2 x 1 mL) (COLD SHIPMENT REQUIRED) | |
| 1700512 | Tryptophan Related Compound A (15 mg) ((2S,2'S)-3,3'-[Ethane-1,1-diylbis(1H-indole-1,3-diyl)]bis(2-aminopropanoic acid)) | 15 mg |
| 1700523 | Tryptophan Related Compound B (25 mg) (N-Acetyl-L-Tryptophan) | 25 mg |
| 1702008 | Tubocurarine Chloride (175 mg) | 175 mg |
| 1703805 | Tylosin (250 mg) | 250 mg |
| 1703850 | Tylosin Tartrate (100 mg) | 100 mg |
| 1704003 | Tyloxapol (3 x 200 mg) | 600 mg |
| 1705301 | Ubidecarenone (200 mg) (COLD SHIPMENT REQUIRED) | 200 mg |
| 1705323 | Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9) (COLD SHIPMENT REQUIRED) | 15 mg |
| 1705312 | Ubidecarenone for System Suitability (25 mg) (COLD SHIPMENT REQUIRED) | 25 mg |
| 1705334 | Ubiquinol (5 x 50 mg) | 250 mg |
| 1705505 | Undecylenic Acid (200 mg) | 200 mg |
| 1705753 | Uracil (15 mg) | 15 mg |
| 1705800 | Uracil Arabinoside (50 mg) | 50 mg |
| 1706698 | Urea (200 mg) | 200 mg |
| 1706701 | Urea C 13 (150 mg) | 150 mg |
| 1706712 | Urea Related Compound A (15 mg) (Dicarbonimidic diamide) | 15 mg |
| 1707114 | Uridine (30 mg) (1-Beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione) | 30 mg |
| 1707806 | Ursodiol (125 mg) | 125 mg |
| 1707770 | Ursolic Acid (25 mg) | 25 mg |
| 1707839 | Valacyclovir Hydrochloride (200 mg) | 200 mg |
| 1707855 | Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride) | 10 mg |
| 1707861 | Valacyclovir Related Compound D (15 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate) | 15 mg |
| 1707872 | Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate) | 25 mg |
| 1707883 | Valacyclovir Related Compound F (25 mg) (2-hydroxyethyl valinate para-toluenesulfonate salt) | 25 mg |
| 1707894 | Valacyclovir Related Compound G (50 mg) (N,N-dimethylpyridin-4-amine) | 50 mg |
| 1707828 | Valacyclovir Related Compound M (15 mg) (9-[(2-Hydroxyethoxy)methyl]guanine N-formyl-l-valinate) | 15 mg |
| 1707908 | Valerenic Acid (30 mg) | 30 mg |
| 1708004 | Valganciclovir Hydrochloride (500 mg) | 500 mg |
| 1708707 | Valproic Acid (500 mg) | 500 mg |
| 1708729 | Valproic Acid Related Compound A (0.25 mL) (2-allylpent-4-enoic acid) | 0.25 mL |
| 1708718 | Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) | 50 mg |
| 1708730 | Valrubicin (100 mg) | 100 mg |
| 1708751 | Valrubicin Resolution Mixture (25 mg) (valrubicin spiked with seven related substances) | 25 mg |
| 1708762 | Valsartan (350 mg) | 350 mg |
| 1708773 | Valsartan Related Compound A (10 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl)}D-valine) | 10 mg |
| 1708784 | Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine) | 10 mg |
| 1708795 | Valsartan Related Compound C (10 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester) | 10 mg |
| 1708810 | Valsartan Related Compound E (15 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester) | 15 mg |
| 1709029 | Vancomycin B (350 mg) | 350 mg |
| 1709018 | Vancomycin B with Monodechlorovancomycin (300 mg) | 300 mg |
| 1709007 | Vancomycin Hydrochloride (4 vials, each vial contains 98,800 mcg of vancomycin activity) | 395200 ug |
| 1710006 | Vanillin (200 mg) | 200 mg |
| 1711009 | Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) | 1 g |
| 1711010 | Vardenafil Hydrochloride (200 mg) | |
| 1711029 | Vardenafil System Suitability (20 mg) | |
| 1711031 | Vasicine (20 mg) | 20 mg |
| 1711100 | Vasopressin (1.68 mg) (8-L-arginine vasopressin) (COLD SHIPMENT REQUIRED) | 1.68 mg |
| 1711155 | Vecuronium Bromide (50 mg) | 50 mg |
| 1711166 | Vecuronium Bromide Related Compound A (25 mg) (3alpha,17Beta-diacetyl-oxy-2Beta, 16Beta-bispiperidinyl-5alpha-androstan) | 25 mg |
| 1711177 | Vecuronium Bromide Related Compound B (15 mg) (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | 15 mg |
| 1711188 | Vecuronium Bromide Related Compound C (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | 15 mg |
| 1711224 | Vecuronium Bromide Related Compound F (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | 15 mg |
| 1711268 | Venlafaxine Hydrochloride (100 mg) | 100 mg |
| 1711279 | Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride) | 10 mg |
| 1711202 | Verapamil Hydrochloride (200 mg) | 200 mg |
| 1711304 | Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) | 50 mg |
| 1711406 | Verapamil Related Compound B (50 mg) (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride) | 50 mg |
| 1711439 | Verapamil Related Compound E (50 mg) (3,4-dimethoxybenzaldehyde) | 50 mg |
| 1711440 | Verapamil Related Compound F (150 mg) ((3,4-Dimethoxyphenyl)methanol) | 150 mg |
| 1711455 | Verbascoside (15 mg) (2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-Beta-D-glucopyranoside) | 15 mg |
| 1711461 | Verteporfin (200 mg) | 200 mg |
| 1711472 | Verteporfin Related Compound A (50 mg) ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid) | 50 mg |
| 1712001 | Vigabatrin (200 mg) | 200 mg |
| 1712012 | Vigabatrin Related Compound A (50 mg) (5-vinylpyrrolidin-2-one) | 50 mg |
| 1712023 | Vigabatrin Related Compound B (30 mg) ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride) | 30 mg |
| 1712045 | Vigabatrin Related Compound E (30 mg) (2-(2-aminobut-3-enyl)malonic acid) | 30 mg |
| 1713004 | Vinblastine Sulfate (50 mg) | 50 mg |
| 1714007 | Vincristine Sulfate (50 mg) | 50 mg |
| 1714018 | Vincristine Sulfate (Assay) (29.8 mg/vial) | 29.8 mg |
| 1714528 | Vinorelbine Related Compound A (25 mg) (4-O-Deacetylvinorelbine tartrate) | 25 mg |
| 1714506 | Vinorelbine Tartrate (200 mg) | 200 mg |
| 1714608 | Vinpocetine (100 mg) | 100 mg |
| 1714619 | Vinpocetine Related Compound A (30 mg) (ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) | 30 mg |
| 1714620 | Vinpocetine Related Compound B (30 mg) (Methyl(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) | 30 mg |
| 1714641 | Vinpocetine Related Compound C (30 mg) (ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) | 30 mg |
| 1714652 | Vinpocetine Related Compound D (30 mg) (ethyl(12R,13aS,13bS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) | 30 mg |
| 1717504 | Vitamin D Assay System Suitability (1.5 g) | 1.5 g |
| 1717708 | Vitexin (25 mg) ((1S)-1,5-Anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol) | 25 mg |
| 1718008 | Voriconazole (100 mg) | 100 mg |
| 1718019 | Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | 10 mg |
| 1718020 | Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | 10 mg |
| 1718039 | Voriconazole Related Compound C (10 mg) (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone) | 10 mg |
| 1718041 | Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | 10 mg |
| 1718063 | Voriconazole Related Compound F (50 mg) ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulphonic acid) | 50 mg |
| 1719000 | Warfarin (200 mg) | 200 mg |
| 1719102 | Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) | 50 mg |
| 1719500 | Withanolide A (15 mg) | 15 mg |
| 1719532 | Withanoside IV (15 mg) | 15 mg |
| 1720000 | Xanthanoic Acid (100 mg) | 100 mg |
| 1720203 | Xanthone (100 mg) | 100 mg |
| 1720407 | Xylazine (200 mg) | 200 mg |